Key facts
- This page summarizes Ramesh Ramakrishnan's Form 4 filing for Talis Biomedical Corp.
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2021, 17:01.
Ramesh Ramakrishnan - 13 Aug 2021 Form 4 Insider Report for Talis Biomedical Corp
- Reporting relationship
- Former Officer
- Issuer ticker
- N/A
- Reported as of
- 13 Aug 2021
- Net transaction value
- -$132,133
- Reporting owner signature
- /s/ J. Roger Moody, Jr., Attorney-in-Fact for Ramesh Ramakrishnan
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ramesh Ramakrishnan filed Form 4 for Talis Biomedical Corp on 17 Aug 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$132,133.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TLIS
transaction
Common Stock
Options Exercise
- Transaction value
- $65,421
- Shares
- +43,614
- Change %
- +317%
- Price
- $1.50
- Shares after
- 57,380
- Date
- 13 Aug 2021
- Ownership
- Direct
TLIS
transaction
Common Stock
Options Exercise
- Transaction value
- $13,112
- Shares
- +8,741
- Change %
- +15%
- Price
- $1.50
- Shares after
- 66,121
- Date
- 13 Aug 2021
- Ownership
- Direct
TLIS
transaction
Common Stock
Sale
- Transaction value
- $210,665
- Shares
- -27,502
- Change %
- -42%
- Price
- $7.66
- Shares after
- 38,619
- Date
- 13 Aug 2021
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TLIS
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -43,614
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 43,614
- Exercise price
- $1.50
- Footnotes
- F2
TLIS
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -8,741
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 13 Aug 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 8,471
- Exercise price
- $1.50
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Ramesh Ramakrishnan is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
Footnote F2
1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.
Footnote F3
25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.